New Delhi, April 10 (Ians) The Supreme Court on Monday dismissed a plea alleging use of drugs Remdesivir and Favipiravir, without approval, for treatment of Covid-19 and also seeking Cbi probe against ten Indian pharmaceutical firms for selling these medicines allegedly in the absence of valid licenses.
A bench, headed by Chief Justice of India D.Y. Chandrachud and comprising Justices P.S. Narasimha and J.B. Pardiwala said these issues cannot be examined by the court and dismissed the plea filed by advocate M.L. Sharma.
In October 2020, the Supreme Court had sought Centre’s reply on the plea alleging that Remdesivir and Favipiravir are being used for treatment of Covid-19 without approval.
A bench headed by then Chief Justice S.A. Bobde had issued notice to the Centre on the plea and sought its response in four weeks.
Sharma, petitioner in-person, had then cited the World Health Organisation (Who) report...
A bench, headed by Chief Justice of India D.Y. Chandrachud and comprising Justices P.S. Narasimha and J.B. Pardiwala said these issues cannot be examined by the court and dismissed the plea filed by advocate M.L. Sharma.
In October 2020, the Supreme Court had sought Centre’s reply on the plea alleging that Remdesivir and Favipiravir are being used for treatment of Covid-19 without approval.
A bench headed by then Chief Justice S.A. Bobde had issued notice to the Centre on the plea and sought its response in four weeks.
Sharma, petitioner in-person, had then cited the World Health Organisation (Who) report...
- 4/10/2023
- by Agency News Desk
- GlamSham
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.